Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luise Linsenmeier

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biochimica Et Biophysica Acta. Molecular Cell Research|July 12, 2017
Diverse functions of the prion protein - Does proteolytic processing hold the key?Luise Linsenmeier, Hermann C Altmeppen, Sebastian Wetzel, et al.
Prion|July 18, 2015
Shedding light on prion diseaseMarkus Glatzel, Luise Linsenmeier, Frank Dohler, et al.
Plos Pathogens|January 5, 2019
GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in miceBerta Puig, Hermann C Altmeppen, Luise Linsenmeier, et al.
Scientific Reports|April 28, 2016
Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in miceBerta Puig, Hermann C Altmeppen, Sarah Ulbrich, et al.
Molecular Neurodegeneration|April 8, 2018
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion proteinLuise Linsenmeier, Behnam Mohammadi, Sebastian Wetzel, et al.
Molecular Neurobiology|May 6, 2020
Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER TranslocationBehnam Mohammadi, Luise Linsenmeier, Mohsin Shafiq, et al.
Elife|February 6, 2015
The sheddase ADAM10 is a potent modulator of prion diseaseHermann C Altmeppen, Johannes Prox, Susanne Krasemann, et al.
Acta Neuropathologica|November 2, 2019
Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prionsPatricia Aguilar-Calvo, Alejandro M Sevillano, Jaidev Bapat, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Communications Biology|January 13, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediateGiovanni Spagnolli, Tania Massignan, Andrea Astolfi, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. Molecular Cell Research|July 12, 2017
Diverse functions of the prion protein - Does proteolytic processing hold the key?Luise Linsenmeier, Hermann C Altmeppen, Sebastian Wetzel, et al.
Prion|July 18, 2015
Shedding light on prion diseaseMarkus Glatzel, Luise Linsenmeier, Frank Dohler, et al.
Plos Pathogens|January 5, 2019
GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in miceBerta Puig, Hermann C Altmeppen, Luise Linsenmeier, et al.
Scientific Reports|April 28, 2016
Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in miceBerta Puig, Hermann C Altmeppen, Sarah Ulbrich, et al.
Molecular Neurodegeneration|April 8, 2018
Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion proteinLuise Linsenmeier, Behnam Mohammadi, Sebastian Wetzel, et al.
Molecular Neurobiology|May 6, 2020
Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER TranslocationBehnam Mohammadi, Luise Linsenmeier, Mohsin Shafiq, et al.
Elife|February 6, 2015
The sheddase ADAM10 is a potent modulator of prion diseaseHermann C Altmeppen, Johannes Prox, Susanne Krasemann, et al.
Acta Neuropathologica|November 2, 2019
Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prionsPatricia Aguilar-Calvo, Alejandro M Sevillano, Jaidev Bapat, et al.
Science Advances|November 24, 2021
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathiesLuise Linsenmeier, Behnam Mohammadi, Mohsin Shafiq, et al.
Communications Biology|January 13, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediateGiovanni Spagnolli, Tania Massignan, Andrea Astolfi, et al.
Pageof 2